Yong Duk Han

Jun 7, 2024 | mdpi.com | Tianwei Lu |Yong Duk Han |Qicheng Zhou |Li Dong

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jan 19, 2024 | science.org | Jian-Ting Li |Grace Brown |Chiho Kim |Yong Duk Han

Research ArticleSTEM CELLSGrace E. Brown https://orcid.org/0000-0002-1071-0108, Yong Duk Han, [...] , Ashlin R. Michell https://orcid.org/0000-0002-7563-4345, Olivia T. Ly, [...] , Carlos G. Vanoye https://orcid.org/0000-0002-4935-1122, Emanuele Spanghero https://orcid.org/0000-0003-3891-1961, Alfred L. George Jr. https://orcid.org/0000-0002-3993-966X, Dawood Darbar https://orcid.org/0000-0002-4103-5977 [email protected], and Salman R.

Jan 19, 2024 | sciencemag.org | Jian-Ting Li |Grace Brown |Chiho Kim |Yong Duk Han

Research ArticleSTEM CELLSINTRODUCTIONAtrial fibrillation (AF), the most prevalent arrhythmia requiring therapy, affects >33 million patients worldwide (1), and the prevalence is projected to double over the next 40 years due to the concomitant rise in risk factors and aging of the population (2). Even asymptomatic cases of AF can increase the risk of stroke, myocardial infarction, and heart failure (3).